Hosted on MSN2mon
Seattle biotech firm Athira Pharma will pay $4M to settle allegations related to research misconductAthira raised $204 million in its IPO and was valued at around $670 million when it went public in 2020. The company’s market capitalization is now less than $25 million.
Following Athira’s receipt of the topline results of LIFT-AD, the company made the determination to explore strategic alternatives focused on maximizing stockholder value. Athira engaged Cantor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results